Surgical Glue Market By Type (Fibrin Sealants, Cyanoacrylate-based Adhesives, Albumin-based Adhesives, Collagen-based Adhesives), By Application (Wound Closure, Bone Adhesion, Tissue Repair, Vascular Closure), By End-Use Industry (Hospitals, Ambulatory Surgical Centers, Clinics), By Distribution Channel (Direct Sales, Distributors, Online Retailers), and By Region; Global Insights & Forecast (2024 - 2030)

As per Intent Market Research, the Surgical Glue Market was valued at USD 1.3 billion in 2023 and will surpass USD 2.6 billion by 2030; growing at a CAGR of 10.4% during 2024 - 2030.

The surgical glue market is gaining significant traction due to its critical role in modern surgical procedures, offering an efficient alternative to traditional sutures and staples. Surgical glues are designed to provide quick and effective wound closure, minimize scarring, and reduce the risk of infection, making them highly valuable in both minor and major surgeries. With advancements in medical technology and increasing demand for minimally invasive procedures, the adoption of surgical adhesives is expanding rapidly across various specialties, including wound care, tissue repair, and bone adhesion.

The growing preference for faster recovery times and reduced complication risks is driving the demand for surgical glue. Surgeons are increasingly opting for adhesives that not only offer strong bonding capabilities but also promote healing and tissue regeneration. As the healthcare industry evolves toward more patient-centric solutions, surgical glues are becoming an integral part of surgical toolkits. The market is also benefiting from innovations in adhesive formulations that are more biocompatible and effective in diverse surgical applications.

Cyanoacrylate-based Adhesives Segment Is Largest Owing to High Efficiency and Versatility

The cyanoacrylate-based adhesives segment is the largest in the surgical glue market, owing to their high efficiency and versatility in a wide range of surgical applications. These adhesives are known for their strong bonding capabilities, fast setting times, and ability to be used in both external wound closure and internal applications. Cyanoacrylate adhesives are particularly favored in minimally invasive surgeries and emergency wound closure due to their ease of use and effectiveness in providing immediate closure with minimal tissue reaction.

Cyanoacrylate-based adhesives are also cost-effective and widely available, making them the preferred choice for hospitals and surgical centers across the globe. Their ability to bond quickly and securely, combined with their minimal risk of infection, positions them as the leading choice in the surgical glue market. As surgical procedures continue to evolve, the demand for cyanoacrylate-based adhesives is expected to grow, particularly in high-volume surgeries such as plastic and reconstructive surgery, trauma care, and orthopedic operations.

Fibrin Sealants Segment Is Fastest Growing Owing to Biocompatibility and Enhanced Healing

The fibrin sealants segment is the fastest-growing in the surgical glue market, primarily due to their biocompatibility and ability to enhance healing. Fibrin sealants are derived from human or animal fibrinogen and thrombin, which, when mixed, form a clot that mimics the body’s natural healing process. These adhesives are highly effective in surgeries requiring tissue repair, such as in vascular surgery, liver resection, and soft tissue reconstruction, where natural tissue bonding is crucial.

Fibrin sealants are gaining popularity for their ability to promote rapid tissue regeneration, minimize bleeding, and reduce scarring. Their use is particularly expanding in complex surgeries and in patients with chronic conditions, as they offer enhanced safety and better outcomes compared to other adhesive types. The growing preference for biocompatible materials and less invasive healing methods is driving the rapid adoption of fibrin sealants, making them a key segment in the surgical glue market.

Wound Closure Application Segment Is Largest Due to Widespread Use in Surgical Procedures

The wound closure application segment dominates the surgical glue market, as adhesives are extensively used in a variety of surgical procedures to close incisions, cuts, and wounds. Surgical glues for wound closure offer the advantage of reducing suturing time, minimizing infection risk, and promoting faster healing compared to traditional methods. These adhesives are particularly beneficial in dermatologic, plastic, and emergency surgeries where speed and precision are critical.

As more hospitals and surgical centers move toward adopting less invasive and more efficient closure methods, the demand for surgical glues in wound closure is growing. The ability of surgical adhesives to provide a waterproof, flexible bond that adapts to the natural movement of the skin further drives their popularity. As such, the wound closure application is expected to continue to be the largest segment in the surgical glue market, with growing use in both elective and emergency surgeries.

Hospitals End-Use Industry Segment Is Largest Owing to High Surgery Volume

The hospitals end-use industry segment is the largest in the surgical glue market, driven by the high volume of surgical procedures performed in hospital settings. Hospitals are the primary locations for complex surgeries and emergency treatments, making them the largest consumers of surgical adhesives. The growing number of surgical interventions worldwide, along with the shift towards outpatient surgeries, is increasing the demand for advanced surgical adhesives that ensure faster healing and reduce post-operative complications.

Hospitals are increasingly adopting surgical glues as part of their standard surgical kits, particularly for high-risk surgeries, wound closure, and minimally invasive procedures. The convenience, safety, and effectiveness offered by surgical glues align well with the requirements of hospital-based surgeries, further reinforcing their widespread use. As surgical volumes continue to rise globally, hospitals will remain the dominant end-user in the surgical glue market.

Direct Sales Distribution Channel Segment Is Largest Owing to Strong Relationships with Healthcare Providers

The direct sales distribution channel is the largest in the surgical glue market, driven by the strong relationships between manufacturers and healthcare providers. Direct sales allow for better customer service, tailored product offerings, and more effective supply chain management, ensuring that hospitals, clinics, and surgical centers receive the necessary adhesives promptly. Manufacturers often have dedicated sales teams that work closely with healthcare professionals to meet the specific needs of surgical departments and offer product training.

This distribution method also allows manufacturers to maintain direct control over their products, ensuring higher quality standards and reducing the risk of counterfeit products entering the market. As demand for surgical glues continues to rise, the direct sales channel is expected to remain dominant, particularly in regions where the healthcare infrastructure is well-established.

North America Region Is Largest Owing to Advanced Healthcare Infrastructure and High Adoption Rate

North America holds the largest share of the surgical glue market, primarily due to its advanced healthcare infrastructure and high adoption rate of innovative medical technologies. The United States, in particular, is a major hub for medical device development and healthcare innovation, making it a leading market for surgical adhesives. The presence of numerous hospitals, ambulatory surgical centers, and medical research institutions further supports the demand for surgical glues in the region.

Additionally, the growing emphasis on minimally invasive surgeries and patient-centric care is driving the adoption of surgical adhesives as a faster and less invasive alternative to traditional sutures and staples. With healthcare spending in North America remaining high, the region is expected to continue leading the surgical glue market in the coming years, supported by strong healthcare systems and high surgical volumes.

Leading Companies and Competitive Landscape

The surgical glue market is highly competitive, with key players such as Johnson & Johnson, B. Braun Melsungen, Medtronic, and Smith & Nephew leading the industry. These companies are focusing on expanding their product portfolios, enhancing the efficacy of their adhesives, and targeting specific surgical applications.

Innovation plays a central role in the competitive landscape, as manufacturers strive to develop glues that offer improved biocompatibility, faster setting times, and enhanced bonding strength. Partnerships, acquisitions, and the development of new product lines are common strategies used by these companies to stay ahead in the market. As the market continues to grow, competition is expected to intensify, with companies focusing on differentiating their offerings through technology and product innovation.

Recent Developments:

• In December 2024, Johnson & Johnson (Ethicon) launched a new cyanoacrylate-based surgical glue aimed at reducing surgical site infections.
• In November 2024, Medtronic introduced an albumin-based adhesive for bone adhesion in orthopedic surgeries.
• In October 2024, B. Braun Melsungen AG expanded its portfolio with a new collagen-based surgical glue for tissue repair.
• In September 2024, Smith & Nephew announced the release of an advanced fibrin sealant for vascular surgeries.
• In August 2024, CryoLife, Inc. entered into a strategic partnership with a hospital group to supply its surgical adhesives for complex wound closure procedures.

List of Leading Companies:

• Johnson & Johnson (Ethicon)
• Medtronic
• B. Braun Melsungen AG
• 3M Company
• Smith & Nephew
• Baxter International Inc.
• CryoLife, Inc.
• Cohera Medical, Inc.
• Tissue Regenix Group
• Integra LifeSciences Corporation
• Covalon Technologies Ltd.
• Henkel AG & Co. KGaA
• PermaFix Environmental Services, Inc.
• Mölnlycke Health Care
• Tissuemed Ltd.

Report Scope: